Cyclohexanesulfonyl derivatives as GlyT1 inhibitors to treat...

Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S616000

Reexamination Certificate

active

07626056

ABSTRACT:
The present invention provides compounds of formula I:wherein R1is an alkyl, phenyl, heterocyclyl, cycloalkyl, alkoxy, ester, amino or amide group;R2is a phenyl, heterocyclyl, alkyl, cycloalkyl or cycloalkylalkyl group;R3is an alkyl, cycloalkyl, cycloalkylalkyl, amino or heterocyclyl group;R4and R5are hydrogen or alkyl or form a cycloalkyl ring;A is O or N; andm is zero or one;as inhibitors of GlyT1 and thus as useful for treating or preventing diseases such as schizophrenia; with the provision of pharmaceutical compositions, first and second medical uses and methods of treatment.

REFERENCES:
patent: 6127191 (2000-10-01), Graybill et al.
patent: 6201024 (2001-03-01), Baxter et al.
patent: 6953806 (2005-10-01), Ackermann et al.
patent: 7335670 (2008-02-01), Dargazanli et al.
patent: 2005/0272774 (2005-12-01), Ackermann et al.
patent: 2007/0105902 (2007-05-01), Lindsley et al.
patent: 2007/0249606 (2007-10-01), Lindsley et al.
patent: 2007/0254880 (2007-11-01), Blackaby et al.
patent: 2008/0021010 (2008-01-01), Lindsley et al.
patent: 2008/0090796 (2008-04-01), Blackaby et al.
patent: 2008/0108663 (2008-05-01), Lindsley et al.
patent: 2 861 073 (2003-10-01), None
patent: WO 03/053919 (2003-07-01), None
patent: WO 2005/046601 (2005-05-01), None
patent: WO 2006/131711 (2006-12-01), None
patent: WO 2006/131713 (2006-12-01), None
Foster, et al., “Glutamate- and GABA-based CNS therapeutics”, Current Opinion in Pharmacology, 2006, vol. 6: pp. 7-17.
International Preliminary Report on Patentability for PCT/GB2006/002035.
International Preliminary Report on Patentability for PCT/GB2006/0022052.
Copending U.S. Appl. No. 11/922,074, filed Jun. 13, 2006, U.S. National Stage Entry of PCT/GB06/002156, published as WO 2006/134341.
Copending U.S. Appl. No. 11/991,727, filed Sep. 25, 2006, U.S. National Stage Entry of PCT/GB06/036989, published as WO 2007/041025.
Copending U.S. Appl. No. 12/084,027, filed Oct. 27, 2006, U.S. National Stage Entry of PCT/GB06/041699, published as WO 2007/053400.
Copending U.S. Appl. No. 12/085,340, filed Nov. 23, 2006, U.S. National Stage Entry of PCT/GB06/050411, published as WO 2007/060484.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cyclohexanesulfonyl derivatives as GlyT1 inhibitors to treat... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclohexanesulfonyl derivatives as GlyT1 inhibitors to treat..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclohexanesulfonyl derivatives as GlyT1 inhibitors to treat... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4122859

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.